$CANF breakout $4.00 www.canfite.co.il/upload
Post# of 63848
Posted On: 11/23/2014 9:02:29 PM
$CANF breakout $4.00
Website
Shares Outstanding: 8.85M
Float: 7.90M
Headlines
Wednesday, November 19, 2014
Small Cap IR Initiates Coverage of Can-Fite Biopharma: Newly Discovered Late Clinical Stage BioPharma Vendor with Potentially Revolutionary BreakthroughsPR Newswire
Tuesday, November 18, 2014
Coverage initiated on Can-Fite BioPharma by H.C. WainwrightBriefing.com
Can-Fite Near-Term Milestones Timetable for 2014/2015PR Newswire
Monday, November 17, 2014
Can-Fite Announces Special General Meeting of Shareholders to Elect External DirectorPR Newswire
Thursday, November 13, 2014
Can-Fite CEO Dr. Pnina Fishman to Present Recently Released Positive Data from its Rheumatoid Arthritis Phase IIb Study at the 2014 American College of Rheumatology Annual MeetingPR Newswire
Thursday, October 30, 2014
Can-Fite to Participate in BIO-Europe International Partnering ConferencePR Newswire
Monday, October 20, 2014
3 Stocks Pushing The Drugs Industry Lowerat TheStreet
Wednesday, October 15, 2014
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4%Zacks
Tuesday, October 7, 2014
Can-Fite CEO Dr. Pnina Fishman to Co-Chair and Present at the 19th World Congress on Advances in Oncology's Cancer Therapeutics SessionPR Newswire
Tuesday, September 30, 2014
U.S. Patent and Trademark Office Issues Can-Fite Patent for CF102 in the Treatment of Liver
Wednesday, September 17, 2014
Can-Fite Files June 30, 2014 Interim Financial StatementsPR Newswire
Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of PsoriasisPR Newswire
Friday, September 5, 2014
[$$] Three Biotechs Ready to Partner Upat Barrons.com
Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following SurgeryPR Newswire
Wednesday, September 3, 2014
Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014PR Newswire
Tuesday, September 2, 2014
Can-Fite Reports First Six Months 2014 ResultsPR Newswire
Wednesday, August 6, 2014
New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis PatientsPR Newswire
Monday, July 21, 2014
Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014PR Newswire
Thursday, July 10, 2014
Can-Fite CF102 approved for compassionate use in Israelat theflyonthewall.com
Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer PatientPR Newswire
Website
Shares Outstanding: 8.85M
Float: 7.90M
Headlines
Wednesday, November 19, 2014
Small Cap IR Initiates Coverage of Can-Fite Biopharma: Newly Discovered Late Clinical Stage BioPharma Vendor with Potentially Revolutionary BreakthroughsPR Newswire
Tuesday, November 18, 2014
Coverage initiated on Can-Fite BioPharma by H.C. WainwrightBriefing.com
Can-Fite Near-Term Milestones Timetable for 2014/2015PR Newswire
Monday, November 17, 2014
Can-Fite Announces Special General Meeting of Shareholders to Elect External DirectorPR Newswire
Thursday, November 13, 2014
Can-Fite CEO Dr. Pnina Fishman to Present Recently Released Positive Data from its Rheumatoid Arthritis Phase IIb Study at the 2014 American College of Rheumatology Annual MeetingPR Newswire
Thursday, October 30, 2014
Can-Fite to Participate in BIO-Europe International Partnering ConferencePR Newswire
Monday, October 20, 2014
3 Stocks Pushing The Drugs Industry Lowerat TheStreet
Wednesday, October 15, 2014
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4%Zacks
Tuesday, October 7, 2014
Can-Fite CEO Dr. Pnina Fishman to Co-Chair and Present at the 19th World Congress on Advances in Oncology's Cancer Therapeutics SessionPR Newswire
Tuesday, September 30, 2014
U.S. Patent and Trademark Office Issues Can-Fite Patent for CF102 in the Treatment of Liver
Wednesday, September 17, 2014
Can-Fite Files June 30, 2014 Interim Financial StatementsPR Newswire
Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of PsoriasisPR Newswire
Friday, September 5, 2014
[$$] Three Biotechs Ready to Partner Upat Barrons.com
Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following SurgeryPR Newswire
Wednesday, September 3, 2014
Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014PR Newswire
Tuesday, September 2, 2014
Can-Fite Reports First Six Months 2014 ResultsPR Newswire
Wednesday, August 6, 2014
New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis PatientsPR Newswire
Monday, July 21, 2014
Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014PR Newswire
Thursday, July 10, 2014
Can-Fite CF102 approved for compassionate use in Israelat theflyonthewall.com
Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer PatientPR Newswire
(0)
(0)